| human | Q5 |
| P8446 | Gateway to Research person ID | BA2CD305-0C5C-4A24-A91A-0095026116FC |
| P496 | ORCID iD | 0000-0003-4489-7107 |
| P1153 | Scopus author ID | 6602415503 |
| P108 | employer | Sheffield Hallam University | Q1752117 |
| P735 | given name | Christine | Q2087646 |
| Christine | Q2087646 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q45855502 | A preliminary in vitro study into the use of IL-1Ra gene therapy for the inhibition of intervertebral disc degeneration |
| Q61699166 | Advancing cell therapies for intervertebral disc regeneration from the lab to the clinic: Recommendations of the ORS spine section |
| Q46140203 | Altered integrin mechanotransduction in human nucleus pulposus cells derived from degenerated discs |
| Q37207096 | An in vitro study investigating the survival and phenotype of mesenchymal stem cells following injection into nucleus pulposus tissue. |
| Q92970331 | Aquaporin expression in the human and canine intervertebral disc during maturation and degeneration |
| Q50265581 | Bioactive actions of pomegranate fruit extracts on leukemia cell lines in vitro hold promise for new therapeutic agents for leukemia. |
| Q39485465 | Bioactive chemicals from carrot (Daucus carota) juice extracts for the treatment of leukemia |
| Q42448310 | Cannabinoid WIN-55,212-2 mesylate inhibits interleukin-1β induced matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human chondrocytes |
| Q38005189 | Cannabinoids: novel therapies for arthritis? |
| Q36392389 | Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1beta and TNFalpha expression profile. |
| Q36955390 | Caveolin-1 expression and stress-induced premature senescence in human intervertebral disc degeneration. |
| Q61699186 | Connective tissue growth factor expression in human intervertebral disc: implications for angiogenesis in intervertebral disc degeneration |
| Q34580505 | Current understanding of cellular and molecular events in intervertebral disc degeneration: implications for therapy. |
| Q61699204 | Degeneration of intervertebral discs: current understanding of cellular and molecular events, and implications for novel therapies |
| Q38271248 | Degeneration of the intervertebral disc with new approaches for treating low back pain. |
| Q39979468 | Development of an in vitro model to test the efficacy of novel therapies for IVD degeneration |
| Q39135747 | Differential effects of polyphenols on proliferation and apoptosis in human myeloid and lymphoid leukemia cell lines. |
| Q47876773 | Do intervertebral discs degenerate before they herniate, or after? |
| Q28348656 | Dual colour FISH in paraffin wax embedded bone trephines for identification of numerical and structural chromosomal abnormalities in acute myeloid leukaemia and myelodysplasia |
| Q39409102 | Effects of bioactive compounds from carrots (Daucus carota L.), polyacetylenes, beta-carotene and lutein on human lymphoid leukaemia cells |
| Q38957636 | Expression and regulation of neurotrophic and angiogenic factors during human intervertebral disc degeneration |
| Q37454079 | Expression of cartilage-derived morphogenetic protein in human intervertebral discs and its effect on matrix synthesis in degenerate human nucleus pulposus cells |
| Q53649822 | Expression of receptors for putative anabolic growth factors in human intervertebral disc: implications for repair and regeneration of the disc. |
| Q43076940 | Glutathione is key to the synergistic enhancement of doxorubicin and etoposide by polyphenols in leukaemia cell lines. |
| Q92347459 | Hedgehog proteins and parathyroid hormone-related protein are involved in intervertebral disc maturation, degeneration, and calcification |
| Q61699188 | Human cells derived from degenerate intervertebral discs respond differently to those derived from non-degenerate intervertebral discs following application of dynamic hydrostatic pressure |
| Q53586255 | Human disc degeneration is associated with increased MMP 7 expression. |
| Q113914843 | Hyperosmolar expansion medium improves nucleus pulposus cell phenotype |
| Q100440225 | Immunohistochemical analysis of protein expression in formalin fixed paraffin embedded human intervertebral disc tissues |
| Q100440242 | Improving reproducibility in spine research |
| Q28583559 | Inflammatory cytokines induce NOTCH signaling in nucleus pulposus cells: implications in intervertebral disc degeneration |
| Q51654787 | Inhibiting IL-1 signaling pathways to inhibit catabolic processes in disc degeneration. |
| Q59683291 | Interleukin-1 receptor antagonist deficient mice provide insights into pathogenesis of human intervertebral disc degeneration |
| Q28822618 | Investigation of intervertebral disc degeneration using multivariate FTIR spectroscopic imaging |
| Q61699189 | Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc |
| Q61699167 | Leaping the hurdles in developing regenerative treatments for the intervertebral disc from preclinical to clinical |
| Q61699199 | Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc |
| Q61796773 | Long-term in vitro 3D hydrogel co-culture model of inflammatory bowel disease |
| Q36883824 | Matrix synthesis and degradation in human intervertebral disc degeneration. |
| Q92970340 | Mesenchymal stem cell therapies for intervertebral disc degeneration: Consideration of the degenerate niche |
| Q61699191 | Microgel particles containing methacrylic acid: pH-triggered swelling behaviour and potential for biomaterial application |
| Q40006569 | Modified expression of the ADAMTS enzymes and tissue inhibitor of metalloproteinases 3 during human intervertebral disc degeneration |
| Q26764941 | Molecular mechanisms of biological aging in intervertebral discs |
| Q61699202 | Nerve growth factor expression and innervation of the painful intervertebral disc |
| Q43101289 | Nerves are more abundant than blood vessels in the degenerate human intervertebral disc. |
| Q36771759 | Nucleus pulposus phenotypic markers to determine stem cell differentiation: fact or fiction? |
| Q36110039 | Polyphenols act synergistically with doxorubicin and etoposide in leukaemia cell lines |
| Q52837664 | Potential roles of cytokines and chemokines in human intervertebral disc degeneration: interleukin-1 is a master regulator of catabolic processes. |
| Q64062738 | Recapitulating Parkinson's disease pathology in a three-dimensional human neural cell culture model |
| Q47418824 | Studies of human intervertebral disc cell function in a constrained in vitro tissue culture system |
| Q37691242 | The cytokine and chemokine expression profile of nucleus pulposus cells: implications for degeneration and regeneration of the intervertebral disc. |
| Q24817050 | The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration |
| Q90673400 | The use of auxetic materials in tissue engineering |
| Q50868237 | Thermally triggered injectable hydrogel, which induces mesenchymal stem cell differentiation to nucleus pulposus cells: Potential for regeneration of the intervertebral disc. |
| Q43239473 | Tumor necrosis factor α- and interleukin-1β-dependent induction of CCL3 expression by nucleus pulposus cells promotes macrophage migration through CCR1. |
| Q92606373 | Use of l-pNIPAM hydrogel as a 3D-scaffold for intestinal crypts and stem cell tissue engineering |
Search more.